| Browse All

Sanara MedTech Inc. (SMTI)

Healthcare | Medical Instruments & Supplies | Fort Worth, United States | NasdaqCM
20.77 USD +0.99 (5.005%) ⇧ (April 17, 2026, 4 p.m. EDT)
After hours: 21.15 +0.38 (1.830%) ⇧ (April 17, 2026, 6:11 p.m. EDT)

Short-term: ★★★☆☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 19, 2026, 12:33 a.m. EDT

SMTI presents a volatile speculative opportunity with a 'buy' consensus driven by a pending turnaround (vizient contract) and low absolute price, despite severely negative earnings, a 31x book value, and a flawed forecasting model that predicts a 2% decline. The stock is trading near a 23% drop from highs, offering downside breathing room for speculative capital, but lacks fundamental stability for investment thesis confirmation in the short term.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.082871
MSTL0.084125
AutoETS0.089440
AutoARIMA0.095572

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 43%
H-stat 11.99
Ljung-Box p 0.000
Jarque-Bera p 0.278
Excess Kurtosis -0.79
Attribute Value
Sector Healthcare
Debt to Equity Ratio 812.727
Revenue per Share 11.958
Market Cap 190,399,424
Forward P/E 40.73
Beta 1.10
Profit Margins -36.43%
Website https://sanaramedtech.com

Info Dump

Attribute Value
52 Week Change -0.27529657
Address1 1,200 Summit Avenue
Address2 Suite 414
All Time High 7,800.0
All Time Low 2.0
Ask 21.27
Ask Size 1
Audit Risk 7
Average Analyst Rating 1.0 - Strong Buy
Average Daily Volume10 Day 50,250
Average Daily Volume3 Month 68,429
Average Volume 68,429
Average Volume10Days 50,250
Beta 1.102
Bid 20.36
Bid Size 1
Board Risk 8
Book Value 0.664
City Fort Worth
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 7
Country United States
Crypto Tradeable 0
Currency USD
Current Price 20.77
Current Ratio 1.801
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 21.49
Day Low 20.09
Debt To Equity 812.727
Display Name Sanara MedTech
Dividend Date 1,557,446,400
Earnings Call Timestamp End 1,778,587,200
Earnings Call Timestamp Start 1,778,587,200
Earnings Timestamp 1,778,589,000
Earnings Timestamp End 1,778,589,000
Earnings Timestamp Start 1,778,589,000
Ebitda 11,807,531
Ebitda Margins 0.11451
Enterprise To Ebitda 18.802
Enterprise To Revenue 2.153
Enterprise Value 222,004,768
Eps Current Year 0.07
Eps Forward 0.51
Eps Trailing Twelve Months -0.05
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 18.9948
Fifty Day Average Change 1.7751999
Fifty Day Average Change Percent 0.09345715
Fifty Two Week Change Percent -27.529657
Fifty Two Week High 35.95
Fifty Two Week High Change -15.18
Fifty Two Week High Change Percent -0.42225313
Fifty Two Week Low 16.05
Fifty Two Week Low Change 4.720001
Fifty Two Week Low Change Percent 0.2940811
Fifty Two Week Range 16.05 - 35.95
Financial Currency USD
First Trade Date Milliseconds 765,725,400,000
Float Shares 3,792,404
Forward Eps 0.51
Forward P E 40.72549
Free Cashflow 8,536,245
Full Exchange Name NasdaqCM
Full Time Employees 108
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 0.92706
Gross Profits 95,597,016
Has Pre Post Market Data 1
Held Percent Insiders 0.64194
Held Percent Institutions 0.13403
Implied Shares Outstanding 9,167,040
Industry Medical Instruments & Supplies
Industry Disp Medical Instruments & Supplies
Industry Key medical-instruments-supplies
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,557,446,400
Last Split Factor 1:100
Long Business Summary Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site and it can be used as a strip or molded into a putty to fill a bone defect; ACTIGEN Inductive Bone Matrix, a naturally derived, differentiated allograft matrix with robust handling properties; ALLOCYTE Plus, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Long Name Sanara MedTech Inc.
Market us_market
Market Cap 190,399,424
Market State CLOSED
Max Age 86,400
Message Board Id finmb_944412
Most Recent Quarter 1,767,139,200
Net Income To Common -387,683
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 192,691,180
Number Of Analyst Opinions 2
Open 20.17
Operating Cashflow 6,786,629
Operating Margins 0.10497
Overall Risk 7
Payout Ratio 0.0
Phone 817 529 2300
Post Market Change 0.37999916
Post Market Change Percent 1.8295578
Post Market Price 21.15
Post Market Time 1,776,463,886
Previous Close 19.78
Price Eps Current Year 296.7143
Price Hint 2
Price To Book 31.280123
Price To Sales Trailing12 Months 1.846423
Profit Margins -0.36426997
Quick Ratio 1.534
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.0
Region US
Regular Market Change 0.99
Regular Market Change Percent 5.00505
Regular Market Day High 21.49
Regular Market Day Low 20.09
Regular Market Day Range 20.09 - 21.49
Regular Market Open 20.17
Regular Market Previous Close 19.78
Regular Market Price 20.77
Regular Market Time 1,776,456,000
Regular Market Volume 106,094
Return On Assets 0.070989996
Return On Equity -0.01753
Revenue Growth 0.047
Revenue Per Share 11.958
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 6
Shares Outstanding 9,167,040
Shares Percent Shares Out 0.0272
Shares Short 249,624
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 216,797
Short Name Sanara MedTech Inc.
Short Percent Of Float 0.056500003
Short Ratio 3.43
Source Interval 15
State TX
Symbol SMTI
Target High Price 36.0
Target Low Price 32.0
Target Mean Price 34.0
Target Median Price 34.0
Total Cash 16,578,857
Total Cash Per Share 1.809
Total Debt 48,192,868
Total Revenue 103,117,984
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.05
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 25.13385
Two Hundred Day Average Change -4.3638496
Two Hundred Day Average Change Percent -0.1736244
Type Disp Equity
Volume 106,094
Website https://sanaramedtech.com
Zip 76,102